GlobalData, the industry
analysis specialist, has released its latest report, "Country Focus: Healthcare
Regulatory and Reimbursement Landscape-The Netherlands". The
report is an essential source of information on analysis of the healthcare,
regulatory and reimbursement landscape in the Netherlands. It identifies the
key trends in the country’s healthcare market and provides insights into its
demographic, regulatory, and reimbursement landscape and healthcare
infrastructure. Most importantly, the report provides valuable insights into
the trends and segmentation of its pharmaceutical and medical device markets.
It uses data and information sourced from proprietary databases, secondary
research, and in-house analysis by GlobalData ‘steam of industry experts.
The value of the
pharmaceuticals market decreased from USD 7.1 billion in 2009 to USD 5.3
billion in 2016 at a negative Compound Annual Growth Rate (CAGR) of 4%, and
this value is expected to decrease further from USD 5.1 billion in 2017 to USD
4.3 billion in 2021 at a negative CAGR of 4%. The medical device market was worth
USD 3.5 billion in 2016 and is projected to reach USD 4.3 billion by 2021 at a
CAGR of 4%.
Scope
The report provides
information on the healthcare, regulatory, and reimbursement landscape in the
Netherlands, and includes an overview of the pharmaceutical and medical device
markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Teva,
Pfizer, Merck, Roche, and AbbVie; and of major players in the medical device
market: Medtronic, Essilor, Roche, Zimmer Biomet, and Ethicon An insightful
review of the reimbursement and regulatory landscape, with analysis covering
details of the country ‘shealthcare reimbursement process, regulatory agencies
and the approval processes for new drugs and medical devices Detailed analysis
of the country’ shealthcare environment, demographics, healthcare
infrastructure and healthcare expenditure An overview of the opportunities for
and challenges to growth in the Netherlands' healthcare market
Key Topics Covered in the Report:
Netherlands
Healthcare Regulatory and Reimbursement Research Report
Netherlands
Healthcare Regulatory Market Trends
Netherlands
Healthcare Regulatory and Reimbursement Market Growth
Netherlands
Healthcare Reimbursement Market Demand
Netherlands
Healthcare Regulatory Market Size
Healthcare
Regulatory and Reimbursement in Netherlands
Netherlands
Healthcare Regulatory and Reimbursement Market Share
Netherlands
Healthcare Regulatory and Reimbursement Market Analysis
Netherlands
Healthcare Reimbursement Industry Research
Netherlands Healthcare Regulatory and
Reimbursement Market Revenue
To know more, click on the link below:
Related reports
Contact:
Ken Research
Ankur Gupta, Head Marketing
& Communications
+91-124-4230204